CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/18/2023
Back to search
Official data from USPTO
POLYTAXEL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
04/18/2023
Trademark type
Word
Nice classes
5
Filing date
07/18/2019
Registration date
06/28/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/28/2022
Last transaction
06/28/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
03
Owner location
Seoul, KR
Examiner
VALLILLO, MELISSA
Law office
L50
Current location
TMEG LAW OFFICE 105
Holders and representatives
Holders
CnPharm Co., Ltd.
Representatives
Samuel S. Lee Procopio, Cory, Hargreaves & Savitch LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of pancreatic tumors; pharmaceutical agents for the treatment of disorders in sensory organs; thyroid and para-thyroid hormone preparations; medicinal tonics for the treatment of pancreatic tumors; oral contraceptive pills; antiemetics; local anesthetics; bronchodilating preparations; anti-cough drops; androgen preparations; pituitary hormone preparations; pharmaceutical preparations for treating diabetes; pharmaceutical agents for use in regulating metabolism; vaccines against flu; chilblain preparations; pharmaceutical preparations for headache; anaesthetics; pharmaceutical for use in the treating disorders of the peripheral nervous system; pharmaceutical preparations for immunity adjustment; nutritive substances for microorganisms for medical purposes; pharmaceutical for the treatment of erectile dysfunction; pharmaceutical preparations for treating disorders of the urogenital organs; vitamin preparations; pharmaceutical preparations for the treatment of bone diseases; anti-inflammatory and antipyretic preparations; pharmaceutical agents for treating disorders of the digestive organs; pharmaceutical preparations for the treatment of cardiovascular disorders; nervines; ophthalmic preparations; allergy medications; chemicopharmaceutical preparations for the treatment of pancreatic disorders; medicines for the treatment of gastrointestinal diseases; mineral injection preparations featuring vitamin supplements for medical purposes; antioxidants for medical purposes; haematogen; pharmaceutical preparations for tumor treatment; multivitamin preparations; suppositories; pharmaceutical preparations for use in the treatment of disorders of the central nervous system; pharmaceutical preparations for diagnosis of cancer; sedatives; analgesics; vaginal washes for medical purposes; pharmaceutical preparations for treating asthma; medicines for treating tooth pain; hemorrhoid preparations; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; vaccines against pneumococcal infections; dermatological pharmaceutical products; contraceptive preparations; antihypertensives; anti-uric preparations; anti-diabetic pharmaceuticals; pharmaceutical preparations for treatment of hemorrhoids; antibiotic preparations; antibiotics; anti-cancer preparations; anti-cancer treatment supplements; antidepressants; anticoagulants; antineoplastics; anti-dermoinfectives; antidotes; antipyretic analgesics; febrifuges; vasoconstrictors; hypoglycemic agents; blood solvent being preparations for treating blood disorders; pharmaceutical preparations for treating disorders of the respiratory organs; respiratory stimulant preparations; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for treating respiratory diseases and asthma; mixed vitamin preparations; preparations for the treatment of burns; disinfectants for chemical toilets; chemotherapeutics; preparations for treatment of hepatitis; preparations for treating colds; preparations for the treatment of hyperlipidemia; preparations for the treatment of hypercholesteremia; pharmaceutical preparations for treating hypertension; pharmaceutical preparations for the treatment of osteoporosis; preparations for the treatment of osteoporosis; injectable pharmaceuticals for treatment of anaphylactic reactions; pharmaceutical preparations for treating halitosis; nausea treatment preparations; antiulcerants; pharmaceutical preparations for the treatment of musculoskeletal disorders; preparations for the treatment of muscle fatigue; pharmaceutical preparations for treating chloasma; pharmaceutical preparations for the treatment of diseases of the endocrine system; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating metabolic disorders; pharmaceutical preparations for treating peripheral nervous system disorders; pharmaceutical preparations for treating dandruff; pharmaceutical preparations for the treatment of rhinitis; pharmaceutical products for the treatment of bone diseases; radioactive pharmaceutical preparations for in vivo diagnostics or therapeutic use; pharmaceutical preparations for the treatment of cancerous cells; medicines for treating intestinal disorders; cardiovascular treatment preparations; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for the treatment of disorders of the metabolic system; pharmaceutical preparations for treating allergies; pharmaceutical preparations and compositions for the treatment and prevention of cancer; biopharmaceuticals for the treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; medicated preparations for the treatment of mouth disorders; transdermal patches for medical treatment of nausea; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of gout; drug delivery agents in the form of dissolvable filmscoatings for tablets that facilitate the delivery of pharmaceutical preparations; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents consisting of compounds that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical preparations; delivery agents in the form of dissolvable films that facilitate the delivery of nutritional supplements; drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; delivery agents in the form of coatings for tablets that facilitate the delivery of nutritional supplements
Publications
History of USPTO decisions and trademark events.
42 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/18/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
04/18/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/18/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/18/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/18/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/28/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
06/28/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/12/2022
PUBO
PUBLISHED FOR OPPOSITION
04/12/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
04/11/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
04/05/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
03/28/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/23/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
03/21/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
03/14/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
03/07/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/05/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
02/28/2022
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
07/30/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
10/13/2020
GNSL
LETTER OF SUSPENSION E-MAILED
10/13/2020
CNSL
SUSPENSION LETTER WRITTEN
10/13/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/13/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/13/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/09/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/19/2020
GNRT
NON-FINAL ACTION E-MAILED
05/19/2020
CNRT
NON-FINAL ACTION WRITTEN
05/19/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/17/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/17/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/17/2020
ALIE
ASSIGNED TO LIE
04/16/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/09/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/26/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/26/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/10/2019
GNRT
NON-FINAL ACTION E-MAILED
10/10/2019
CNRT
NON-FINAL ACTION WRITTEN
10/10/2019
DOCK
ASSIGNED TO EXAMINER
10/07/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/25/2019
NWAP
NEW APPLICATION ENTERED
07/22/2019
Continuous trademark protection
Get notified about every new filing that threatens POLYTAXEL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.